We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.01%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$122B
AUM Growth
+$25.4B
Cap. Flow
+$19.9B
Cap. Flow %
16.27%
Top 10 Hldgs %
24.28%
Holding
7,416
New
435
Increased
3,853
Reduced
2,246
Closed
356

Sector Composition

Rank Sector Weight
1 Technology 7.07%
2 Financials 5.97%
3 Healthcare 5.8%
4 Consumer Discretionary 5.2%
5 Communication Services 4.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSW
5001
CSW Industrials
CSW
$5.66B
$121K ﹤0.01%
2,621
+2,154
+461% +$102K
DOV icon
5002
PUT
Dover
DOV
$28.5B
$121K ﹤0.01%
1,486
-5,571
-79% -$431K
IPI icon
5003
PUT
Intrepid Potash
IPI
$459M
$121K ﹤0.01%
2,540
-1,940
-43% -$75.6K
RDNT icon
5004
CALL
RadNet
RDNT
$5.22B
$121K ﹤0.01%
12,000
+5,400
+82% +$56.3K
THO icon
5005
PUT
Thor Industries
THO
$4.14B
$121K ﹤0.01%
800
-16,700
-95% -$2.32M
SGYP
5006
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$121K ﹤0.01%
54,444
+24,778
+84% +$61.6K
OMED
5007
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$121K ﹤0.01%
29,660
+27,792
+1,488% +$121K
ADVM
5008
DELISTED
Adverum Biotechnologies
ADVM
$120K ﹤0.01%
3,445
+3,000
+674% +$98.7K
EXI icon
5009
iShares Global Industrials ETF
EXI
$1.48B
$120K ﹤0.01%
1,290
VGK icon
5010
Vanguard FTSE Europe ETF
VGK
$31.2B
$120K ﹤0.01%
2,018
-157,118
-99% -$9.17M
AIG.WS
5011
DELISTED
American International Group, Inc.
AIG.WS
$120K ﹤0.01%
6,620
MFGP
5012
PUT
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$120K ﹤0.01%
2,955
-1,385
-32% -$56K
AHRT
5013
AH Realty Trust
AHRT
$526M
$119K ﹤0.01%
7,675
-1,977
-20% -$29.3K
HL icon
5014
PUT
Hecla Mining
HL
$11.1B
$119K ﹤0.01%
29,900
-31,900
-52% -$139K
IAU icon
5015
iShares Gold Trust
IAU
$66.1B
$119K ﹤0.01%
4,780
-13,113
-73% -$322K
INGN icon
5016
CALL
Inogen
INGN
$178M
$119K ﹤0.01%
+1,000
New +$110K
LAUR icon
5017
Laureate Education
LAUR
$5.26B
$119K ﹤0.01%
8,775
-57,872
-87% -$758K
NNBR icon
5018
NN Inc
NNBR
$295M
$119K ﹤0.01%
4,298
-4,541
-51% -$129K
SIRI icon
5019
CALL
SiriusXM
SIRI
$10.2B
$119K ﹤0.01%
2,220
-45,790
-95% -$2.53M
ZYNE
5020
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$119K ﹤0.01%
9,550
+3,723
+64% +$42.7K
ACHN
5021
DELISTED
Achillion Pharmaceuticals
ACHN
$119K ﹤0.01%
41,751
-27,918
-40% -$101K
CRR
5022
CALL
DELISTED
Carbo Ceramics Inc.
CRR
$119K ﹤0.01%
11,700
-38,700
-77% -$342K
VXZ
5023
PUT
DELISTED
iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019
VXZ
$119K ﹤0.01%
6,800
-115,100
-94% -$2.22M
EYE icon
5024
National Vision
EYE
$1.85B
$118K ﹤0.01%
+2,912
New +$95.6K
FISV
5025
PUT
Fiserv Inc
FISV
$29.1B
$118K ﹤0.01%
+1,800
New +$116K

Similar funds

Barclays's Q4 2017 Portfolio in Review

As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.

By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.

  • Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
  • Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
  • Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
  • Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
  • Barclays opened 435 new positions and closed 356 in Q4 2017.
  • Barclays's portfolio value rose 26% quarter-over-quarter to $122B.

Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.